ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…
Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June…
FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in…
NEW YORK, Sept. 19, 2024 /PRNewswire/ -- The Dana-Farber Cancer Institute, a world leader in cancer treatment and research, chose Clinical.ly's…
Partners with ZS Associates and AWS to Develop Groundbreaking First-of-its-kind Gen AI CompanionSTUDIO CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE)…
Launchpad’s Network All Roads Travel (ART) Will Help Raise Brand Awareness for Safety Shot Among Millions of U.S. College Students…
Published data shows that chemotherapy delivered via TAMP with prior chemoradiation in Locally Advanced Pancreatic Cancer observed an Overall Survival…
Topline results expected in fourth quarter of 2024GLEN ALLEN, Va., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:…
- Fourth-quarter revenue of $0.73 million, up 64% year-over-year – - Full-year revenue of $3.11 million, up 148% year-over-year –…
The new version 5.0 of the AI model EDEN™ features a novel toxin antigen predictor, is trained on an expanded…